JPRN-jRCT1080222309未知Unknown
Rozerem Tablets 8mg drug use surveillance: Survey on insomnia associated with sleep-onset difficulty
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 3,000 人开始时间: 2013年11月27日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Sleep-onset difficulty associated with insomnia
排除标准
- •1. Patients with previous history of hypersensitivity to an ingredient of Rozerem Tablets
- •2. Patients with severe liver dysfunction
- •3. Patients taking fluvoxamine maleate
研究者
相似试验
未知
Unknown
Rozerem 8 mg Tablets specified drug-use survey: <Long-term survey on associated with sleep-onset difficulty > - Transitional survey from the preceding drug-use surveyInsomniaJPRN-jRCT1080222454TAKEDA PHARMACEUTICAL COMPANY LTD.100
已完成
不适用
Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset DifficultyInsomniaNCT02058992Takeda3,339
未知
Unknown
Blopress Tablets specified drug-use survey Hypertension: Survey on patients with metabolic syndromeHypertensionJPRN-jRCT1080222516TAKEDA PHARMACEUTICAL COMPANY LTD.15,000
已完成
不适用
THALED CAPSULES Specified Drug Use-results Survey (Crow-Fukase (POEMS) syndrome: Long-term Use)Crow-Fukase (POEMS) syndromeJPRN-UMIN000043600Fujimoto Pharmaceutical Corporation100
已完成
不适用
Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -InsomniaNCT02153086Takeda236